As per RBI’s latest data release, credit growth dipped sharply in April. From 10.9% YoY growth at the beginning of April, it ...

Tata Motors Limited announced that its board committee has nodded to an issue of non-convertible debentures (NCDs) worth up ...

The new capacity addition is part of UltraTech's strategic growth strategy to cater to growing cement demand in domestic as ...

The drug has been chosen as the sole ustekinumab by BCBSM, Florida Healthcare Plan, and other closed-door health systems.

The license will enable Zaakpay to legally enable merchant payments via its web platform, which will enable it to further ...

Net profit for FY2025 increased 31% YoY at ₹1,521 crore. Total revenue for the year increased 20% YoY at ₹4,829 crore.

Although profit increased, the revenue from operations declined 2.2% YoY to ₹864.8 crore from ₹884 crore during Q4FY24.

The operating revenue of the company fell 22.2% year on year at ₹1,016.3 crore in Q4 FY25 from ₹1,305.9 crore in Q4 FY24.

Coromandel International's EBITDA expanded 56% YoY at ₹426.4 crore compared to ₹273.7 crore in the comparable quarter last ...

Company's revenues during FY25 was at ₹5,983.74 crore driven by high volume of orders and robust demand across core segments.

Net interest margin (NIM) also increased to 3.12% in the quarter, showing prudent attempts at balance on both the asset and ...

The company reported net profit of ₹70.8 crore in Q4FY25, from ₹57.1 crore in the corresponding quarter year ago ...